Manufacturing, latest filing in July 2026

APEX Global Solutions Ltd IPO

APEX Global Solutions Ltd filed a Form F-1 registration statement for an initial public offering on 2025-08-19. It has amended it 3 times. It asked for the registration statement to be withdrawn on 2026-07-10. Each fact below is quoted from the filing named with it.

We have applied to list our Class A Ordinary Shares on The Nasdaq Stock Market LLC (“Nasdaq”) under the symbol “APEX.” Trading in our Class A Ordinary Shares will not commence until, among other things, this registration statement on Form F-1 becomes effective and Nasdaq approves our listing application and files its certification with the U.S. Securities and Exchange Commission.From the F-1 filed 2026-02-27

We are offering on a firm commitment basis 2,500,000 Class A ordinary shares, no par value (the “Class A Ordinary Shares”).From the F-1 filed 2026-02-27

We currently estimate that the initial public offering price will be between $4.00 and $5.00 per share.From the F-1/A filed 2025-09-22

We plan to use the net proceeds of this offering for, among others, business expansion, working capital, and general corporate purposes.From the F-1 filed 2026-02-27

Our total revenues increased by S$695,215, or 8.69%, to S$8,696,136 (approximately $6,365,572) for the year ended December 31, 2024, compared to S$8,000,921 for the year ended December 31, 2023.From the F-1 filed 2026-02-27

As a result of the foregoing, our net income amounted to S$100,057 (approximately US$78,665) and S$145,772 for the six months periods ended June 30, 2025 and 2024, respectively.From the F-1 filed 2026-02-27

Pursuant to Rule 477 under the Securities Act of 1933, as amended (the “Securities Act”), the Company hereby requests that the Commission consent to the withdrawal of the Registration Statement, effective as of the date hereof or at the earliest practicable date hereafter.From the RW filed 2026-07-10

Swipe the table sideways to see every column.

Blue-Touch Holdings Group Co., Ltd IPO

Blue-Touch Holdings Group Co., Ltd has a Form F-1 registration statement on file for an initial public offering; the original was filed before the period this page covers, and the earliest filing here is an amendment filed on 2024-10-18. Amendments on record here: 9. It asked for the registration statement to be withdrawn on 2026-07-10. Each fact below is quoted from the filing named with it.

The Company has reserved the symbol “BBCH” for purposes of listing the Ordinary Shares on the Nasdaq Capital Market (“Nasdaq”).From the F-1/A filed 2025-04-25

In the fiscal years ended December 31, 2024, and 2023, the Company’s revenue was $11,598,611 and $9,656,105, respectively, representing a growth rate of approximately 20.12%.From the F-1/A filed 2025-04-25

For the same fiscal years, the Company’s net income was $1,492,520 and $1,131,841, respectively, representing a growth rate of approximately 31.87%.From the F-1/A filed 2025-04-25

Pursuant to Rule 477 under the Securities Act of 1933 (the “Act”), Blue-Touch Holdings Group Co., Ltd (the “Company”) respectfully requests the immediate withdrawal of its Registration Statement on Form F-1 (File No. 333-267699) initially filed with the Securities and Exchange Commission (the “Commission”) on September 30, 2022, together with all exhibits, and amendments thereto (the “Registration Statement”), with such application to be approved effective as of the date hereof or at the earliest practical date thereafter.From the RW filed 2026-07-10

Swipe the table sideways to see every column.

Dear Industrial Gas Inc IPO

Dear Industrial Gas Inc filed a Form S-1 registration statement for an initial public offering on 2026-07-02. As of its latest filing, on 2026-07-02, it has not priced the offering or withdrawn it. Each fact below is quoted from the filing named with it.

We have applied to list our common stocks on the Nasdaq Capital Market under the symbol “KFDE”.From the S-1 filed 2026-07-02

We are offering 5,000,000 ordinary shares of the Company pursuant to this Offering.From the S-1 filed 2026-07-02

Swipe the table sideways to see every column.

GreenVector Holdings Ltd IPO

GreenVector Holdings Ltd filed a Form F-1 registration statement for an initial public offering on 2025-12-19. It has amended it 7 times. It filed its final prospectus on 2026-07-01, at a public offering price of $1.00 per share. Each fact below is quoted from the filing named with it.

We have applied to list our Class A Ordinary Shares on the Nasdaq Capital Market under the symbol “GRVT”.From the F-1/A filed 2026-04-23

We are offering 2,000,000 Class A Ordinary Shares, at a price of $1.00 per Share on a self-underwritten, “best efforts”, no minimum basis.From the 424B4 filed 2026-07-01

We are offering 2,000,000 Class A Ordinary Shares, at a price of $1.00 per Share on a self-underwritten, “best efforts”, no minimum basis.From the 424B4 filed 2026-07-01

By order of priority, we intend to use the net proceeds of this Offering for the purposes below.From the 424B4 filed 2026-07-01

Our direct cost of revenue was US$0.9 million for the six months ended September 30, 2025 as compared to US$1.3 million for the six months ended September 30, 2024, representing a decrease of US$0.4 million, or 34.16%.From the F-1/A filed 2026-06-24

We had net income of US$0.4 million and total comprehensive income of US$0.4 million for the six months ended September 30, 2025.From the F-1/A filed 2026-06-24

Swipe the table sideways to see every column.

Nuclea Energy Inc. IPO

Nuclea Energy Inc. filed a Form F-1 registration statement for an initial public offering on 2026-04-13. It has amended it 6 times. It asked for the registration statement to be withdrawn on 2026-07-31. Each fact below is quoted from the filing named with it.

We plan to apply to list our Shares on the NYSE under the symbol “NCLA.” We will not close this offering unless the NYSE has approved our Shares for listing.From the F-1/A filed 2026-07-01

We currently intend to use the net proceeds from this offering for (i) the expansion of our core technology’s functionality and value, including targeted product development, filing provisional utility patents from the initial tranches, and the establishment of an in -house research and development facility equipped for materials testing, design, and prototyping;From the F-1/A filed 2026-07-01

We have incurred operating losses since our inception; for the fiscal year ended June 30, 2025, we reported a net loss of $251,189, and for the period from August 24, 2023 until June 30, 2024 we reported a net loss of $1,475.From the F-1/A filed 2026-07-01

Pursuant to Rule 477 under the Securities Act of 1933 (the “Act”), Nuclea Energy Inc. (the “Company”) respectfully requests the immediate withdrawal of its Registration Statement on Form F-1 (File No. 333-295006) initially filed with the Securities and Exchange Commission (the “Commission”) on April 13, 2026, together with all exhibits thereto (the “Registration Statement”), with such application to be approved effective as of the date hereof or at the earliest practical date thereafter.From the RW filed 2026-07-31

Swipe the table sideways to see every column.

RanMarine Technology B.V. IPO

RanMarine Technology B.V. filed a Form F-1 registration statement for an initial public offering on 2025-02-14. It has amended it 2 times. It asked for the registration statement to be withdrawn on 2026-07-06. Each fact below is quoted from the filing named with it.

We have applied to Nasdaq Stock Market LLC to have the ADS listed on the Nasdaq Capital Market under the symbol “RAN”.From the F-1/A filed 2025-03-28

This is an initial public offering of 1,850,000 American Depositary Shares (“ADSs”), with each ADS representing one (1) ordinary share of the RanMarine Technology B.V., a company organized under the laws of the Netherlands (the “Company”).From the F-1/A filed 2025-03-28

We intend to use the net proceeds from this offering for the purposes of supporting our facilities, developing our product line and equipment, continued research and development, sales and marketing, reducing our debt, and for general corporate purposes.From the F-1/A filed 2025-03-28

Pursuant to Rule 477 under the Securities Act of 1933, as amended (the “ Securities Act”), RanMarine Technology B.V. (the “Registrant”) respectfully requests the immediate withdrawal of its Registration Statement on Form F-1 (File No. 333-284945) initially filed with the Securities and Exchange Commission (the “Commission”) on February 14, 2025, together with all exhibits thereto (the “Registration Statement”), with such application to be approved effective as of the date hereof or at the earliest practical date thereafter.From the RW filed 2026-07-06

Swipe the table sideways to see every column.

SCHMID Group N.V. IPO

SCHMID Group N.V. filed a Form F-1 registration statement for an initial public offering on 2026-02-17. It has amended it 4 times. As of its latest filing, on 2026-07-17, it has not priced the offering or withdrawn it. Each fact below is quoted from the filing named with it.

Swipe the table sideways to see every column.

Our ordinary shares are listed on Nasdaq under the symbol “SHMD” and our Public Warrants are listed under the symbol “SHMD.W”.From the F-1 filed 2026-07-17

We expect to use the net proceeds that we receive from sales of our Ordinary Shares to Yorkville, if any, under the SEPA for working capital and general corporate purposes.From the F-1 filed 2026-05-19

Swipe the table sideways to see every column.

Scribe Therapeutics, Inc. IPO

Scribe Therapeutics, Inc. filed a Form S-1 registration statement for an initial public offering on 2026-07-02. It has amended it 2 times. It filed its final prospectus on 2026-07-27, at a public offering price of $15.00 per share. Each fact below is quoted from the filing named with it.

Swipe the table sideways to see every column.

Our common stock has been approved for listing on the Nasdaq Global Market, or Nasdaq, under the symbol “SCTX.”From the 424B4 filed 2026-07-27

The initial public offering price is $15.00 per share.From the 424B4 filed 2026-07-27

We currently intend to use the net proceeds from this offering and the concurrent private placement, together with our existing cash and cash equivalents, to advance the development of our lead product candidate, STX-1150; to advance the development of our additional product candidate, STX-1400; to advance the development of our additional product candidate, STX-1200; for continued advancement of our pipeline, partnered programs, our CRISPR-based technologies, including XE and ELXR, and further development of next-generation gene editing technologies and assets; and for working capital and other general corporate purposes.From the 424B4 filed 2026-07-27

Our net losses were $47.8 million and $21.8 million for the years ended December 31, 2024 and 2025, respectively, and $17.4 million for the three months ended March 31, 2026.From the S-1/A filed 2026-07-20

Swipe the table sideways to see every column.

SK hynix Inc. IPO

SK hynix Inc. filed a Form F-1 registration statement for an initial public offering on 2026-06-24. It has amended it 2 times. It filed its final prospectus on 2026-07-10. Each fact below is quoted from the filing named with it.

We have been approved to list the ADSs on the Nasdaq Global Select Market (the “Nasdaq”) under the symbol “SKHY.”From the 424B4 filed 2026-07-10

This is a public offering of American Depositary Shares, or “ADSs,” representing common shares of SK hynix Inc., organized under the laws of the Republic of Korea, or “Korea.” We are offering 177,900,000 ADSs.From the 424B4 filed 2026-07-10

We intend to use the net proceeds we receive from this offering for general corporate purposes, including capital expenditures.From the 424B4 filed 2026-07-10

Our revenue was W 52,576 billion (US$34,510 million) in the first quarter of 2026 and W 17,639 billion in the first quarter of 2025, and W 97,147 billion in 2025 (US$63,765 million), W 66,193 billion in 2024 and W 32,766 billion in 2023.From the F-1/A filed 2026-07-06

Swipe the table sideways to see every column.

Standard Nuclear, Inc. IPO

Standard Nuclear, Inc. filed a Form S-1 registration statement for an initial public offering on 2026-06-18. It has amended it 2 times. It filed its final prospectus on 2026-07-16, at a public offering price of $15.00 per share. Each fact below is quoted from the filing named with it.

Swipe the table sideways to see every column.

We have been approved to list our Class A common stock on the New York Stock Exchange under the symbol “STDN.”From the 424B4 filed 2026-07-16

This is the initial public offering of shares of Class A common stock of Standard Nuclear, Inc. We are offering 10,000,000 shares of our Class A common stock in this offering.From the 424B4 filed 2026-07-16

The initial public offering price per share of our Class A common stock is $15.00.From the 424B4 filed 2026-07-16

We intend to use the net proceeds of this offering for working capital and other general corporate purposes.From the 424B4 filed 2026-07-16

Swipe the table sideways to see every column.

Tarsier Pharma Ltd. IPO

Tarsier Pharma Ltd. filed a Form F-1 registration statement for an initial public offering on 2026-04-21. It has amended it 5 times. As of its latest filing, on 2026-07-16, it has not priced the offering or withdrawn it. Each fact below is quoted from the filing named with it.

We have applied to list our ordinary shares on the New York Stock Exchange (the “NYSE”) under the symbol “TARX”.From the F-1/A filed 2026-07-16

We currently intend to use the net proceeds from this offering as described in “Use of Proceeds . ” You will not have the opportunity, as part of your investment decision, to assess whether the proceeds are being used in a manner which you may consider most appropriate.From the F-1/A filed 2026-07-16

Our net loss for the years ended December 31, 2024 and 2025 were $2,456 thousand and $5,070 thousand, respectively.From the F-1/A filed 2026-07-16

Swipe the table sideways to see every column.